Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rosenwirth

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Infectious Diseases|October 1, 1996
The use of cyclosporine, FK506, and SDZ NIM811 to prevent CD25- quiescent peripheral blood mononuclear cells from producing human immunodeficiency virusJ Borvak, C S Chou, G Van Dyke, et al.
Antiviral Research|December 1, 1994
HIV proteinase inhibitors containing 2-aminobenzylstatine as a novel scissile bond replacement: biochemical and pharmacological characterizationA Billich, B Charpiot, G Fricker, et al.
Journal of Medicinal Chemistry|September 16, 1994
Inhibitors of HIV-1 proteinase containing 2-heterosubstituted 4-amino-3-hydroxy-5-phenylpentanoic acid: synthesis, enzyme inhibition, and antiviral activityD Scholz, A Billich, B Charpiot, et al.
Nature|November 24, 1994
Functional association of cyclophilin A with HIV-1 virionsM Thali, A Bukovsky, E Kondo, et al.
Journal of Leukocyte Biology|September 1, 1994
In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophagesC F Perno, S Aquaro, B Rosenwirth, et al.
Molecular and Cellular Biochemistry|April 28, 1976
Characterization of an adenovirus early protein required for viral DNA replication: a single strand specific DNA binding proteinsA J Levine, P C van der Vliet, B Rosenwirth, et al.
Journal of Medicinal Chemistry|November 1, 1985
5-(Haloalkyl)-2'-deoxyuridines: a novel type of potent antiviral nucleoside analogueH Griengl, M Bodenteich, W Hayden, et al.
Vaccine|February 13, 2001
Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaquesB Rosenwirth, E M Kuhn, J L Heeney, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1996
Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entryR Datema, L Rabin, M Hincenbergs, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1995
SDZ PRI 053, an orally bioavailable human immunodeficiency virus type 1 proteinase inhibitor containing the 2-aminobenzylstatine moietyA Billich, G Fricker, I Müller, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Infectious Diseases|October 1, 1996
The use of cyclosporine, FK506, and SDZ NIM811 to prevent CD25- quiescent peripheral blood mononuclear cells from producing human immunodeficiency virusJ Borvak, C S Chou, G Van Dyke, et al.
Antiviral Research|December 1, 1994
HIV proteinase inhibitors containing 2-aminobenzylstatine as a novel scissile bond replacement: biochemical and pharmacological characterizationA Billich, B Charpiot, G Fricker, et al.
Journal of Medicinal Chemistry|September 16, 1994
Inhibitors of HIV-1 proteinase containing 2-heterosubstituted 4-amino-3-hydroxy-5-phenylpentanoic acid: synthesis, enzyme inhibition, and antiviral activityD Scholz, A Billich, B Charpiot, et al.
Nature|November 24, 1994
Functional association of cyclophilin A with HIV-1 virionsM Thali, A Bukovsky, E Kondo, et al.
Journal of Leukocyte Biology|September 1, 1994
In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophagesC F Perno, S Aquaro, B Rosenwirth, et al.
Molecular and Cellular Biochemistry|April 28, 1976
Characterization of an adenovirus early protein required for viral DNA replication: a single strand specific DNA binding proteinsA J Levine, P C van der Vliet, B Rosenwirth, et al.
Journal of Medicinal Chemistry|November 1, 1985
5-(Haloalkyl)-2'-deoxyuridines: a novel type of potent antiviral nucleoside analogueH Griengl, M Bodenteich, W Hayden, et al.
Vaccine|February 13, 2001
Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaquesB Rosenwirth, E M Kuhn, J L Heeney, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1996
Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entryR Datema, L Rabin, M Hincenbergs, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1995
SDZ PRI 053, an orally bioavailable human immunodeficiency virus type 1 proteinase inhibitor containing the 2-aminobenzylstatine moietyA Billich, G Fricker, I Müller, et al.
Pageof 6